Dorsey Wright & Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-941
Closed -$8K 388
2020
Q2
$8K Buy
+941
New +$8.11K ﹤0.01% 299
2019
Q2
Sell
-1,014
Closed -$6K 349
2019
Q1
$6K Sell
1,014
-1,014
-50% -$7.1K ﹤0.01% 284
2018
Q4
$13K Buy
+2,028
New +$15.5K ﹤0.01% 237

Other funds holding NPTN

Dorsey Wright & Associates's NPTN Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 941 shares — an estimated $8K sold.

Dorsey Wright & Associates first reported a position in NPTN in Q4 2018 and held it in 3 quarters. The position peaked at $13K in Q4 2018. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 941 NEOPHOTONICS CORP shares in Q3 2020, an estimated $8K.
  • Dorsey Wright & Associates first reported a position in NEOPHOTONICS CORP in Q4 2018 and held it in 3 quarters.
  • Dorsey Wright & Associates's NEOPHOTONICS CORP position peaked at $13K in Q4 2018.
  • 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.